EFCC Estonian Fieldbus Competency Centre OÜ

Active Registry code 12775870 OÜ Tallinn Registered 2 Jan 2015
Compare

EFCC Estonian Fieldbus Competency Centre OÜ is a OÜ based in Tallinn, registry code 12775870, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q2 2026 was €0 with employees.

Turnover
0 €
State taxes
—
Labour taxes
—
Employees
—

Q2 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 0 €
    industry median 0 € · companies in the industry: 1 073

Taxes and turnover

Q3 2023 – Q2 2026
Turnover, € Q2 2026: 0 € · industry median 14 545 € · above 2% of the industry
05 00010 00015 00020 000Q3 2023 Company: 0 € Industry median: 13 094 €Q3·23Q4 2023 Company: 0 € Industry median: 15 375 €Q1 2024 Company: 0 € Industry median: 14 938 €Q1·24Q2 2024 Company: 0 € Industry median: 14 999 €Q3 2024 Company: 0 € Industry median: 11 985 €Q3·24Q4 2024 Company: 0 € Industry median: 16 752 €Q1 2025 Company: 0 € Industry median: 15 203 €Q1·25Q2 2025 Company: 0 € Industry median: 14 420 €Q3 2025 Company: 0 € Industry median: 13 763 €Q3·25Q4 2025 Company: 0 € Industry median: 13 976 €Q1 2026 Company: 0 € Industry median: 14 268 €Q1·26Q2 2026 Company: 0 € Industry median: 14 545 €Q2·2605 00010 00015 00020 000Q3 2024 Company: 0 € Industry median: 11 985 €Q4 2024 Company: 0 € Industry median: 16 752 €Q4·24Q1 2025 Company: 0 € Industry median: 15 203 €Q2 2025 Company: 0 € Industry median: 14 420 €Q2·25Q3 2025 Company: 0 € Industry median: 13 763 €Q4 2025 Company: 0 € Industry median: 13 976 €Q4·25Q1 2026 Company: 0 € Industry median: 14 268 €Q2 2026 Company: 0 € Industry median: 14 545 €Q2·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q2 2026 — — — —
Q1 2026 — — — —
Q4 2025 — — — —
Q3 2025 — — — —
Q2 2025 — — — —
Q1 2025 — — — —
Q4 2024 — — — —
Q3 2024 — — — —
Q2 2024 — — — —
Q1 2024 — — — —
Q4 2023 — — — —
Q3 2023 — — — —
Q2 2023 — 348 364 —
Q1 2023 — — — —
Q4 2022 — 688 — —
Q3 2022 — — — —
Q2 2022 — — — —
Q1 2022 — — — —

Financials by year

2016 – 2025
Revenue, € thousand 2025: 0 € · −100.0% vs 2024 · industry median 0 € · above 5% of the industry
0501001502016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 5 624 € Industry median: 0 €20192020 Company: 12 051 € Industry median: 150 €20202021 Company: 11 031 € Industry median: 0 €20212022 Company: 147 232 € Industry median: 103 €20222023 Company: 16 621 € Industry median: 76 €20232024 Company: 93 435 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €20250501001502018 Company: — Industry median: —2019 Company: 5 624 € Industry median: 0 €20192020 Company: 12 051 € Industry median: 150 €2021 Company: 11 031 € Industry median: 0 €20212022 Company: 147 232 € Industry median: 103 €2023 Company: 16 621 € Industry median: 76 €20232024 Company: 93 435 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: -23 € · −101.9% vs 2024 · industry median 0 € · above 35% of the industry
-60 000-40 000-20 000020 00040 00060 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: -4 501 € Industry median: 3 €20192020 Company: 899 € Industry median: 28 €20202021 Company: 3 917 € Industry median: 1 €20212022 Company: 44 343 € Industry median: 0 €20222023 Company: -43 953 € Industry median: 0 €20232024 Company: 1 205 € Industry median: 0 €20242025 Company: -23 € Industry median: 0 €2025-60 000-40 000-20 000020 00040 00060 0002018 Company: — Industry median: —2019 Company: -4 501 € Industry median: 3 €20192020 Company: 899 € Industry median: 28 €2021 Company: 3 917 € Industry median: 1 €20212022 Company: 44 343 € Industry median: 0 €2023 Company: -43 953 € Industry median: 0 €20232024 Company: 1 205 € Industry median: 0 €2025 Company: -23 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2024: 1.3 % · +265.7 pp vs the year before · industry median 15.8 % · above 33% of the industry
-300-200-10001002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: -80.0 % Industry median: 12.7 %20192020 Company: 7.5 % Industry median: 23.8 %20202021 Company: 35.5 % Industry median: 25.1 %20212022 Company: 30.1 % Industry median: 17.7 %20222023 Company: -264.4 % Industry median: 16.8 %20232024 Company: 1.3 % Industry median: 15.8 %20242025 Company: — Industry median: 13.5 %2025-300-200-10001002018 Company: — Industry median: —2019 Company: -80.0 % Industry median: 12.7 %20192020 Company: 7.5 % Industry median: 23.8 %2021 Company: 35.5 % Industry median: 25.1 %20212022 Company: 30.1 % Industry median: 17.7 %2023 Company: -264.4 % Industry median: 16.8 %20232024 Company: 1.3 % Industry median: 15.8 %2025 Company: — Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 4 991 € · −74.0% vs 2024
020 00040 00060 00080 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 13 421 €20192020 Company: 14 158 €20202021 Company: 19 155 €20212022 Company: 79 752 €20222023 Company: 23 697 €20232024 Company: 19 170 €20242025 Company: 4 991 €2025020 00040 00060 00080 0002018 Company: —2019 Company: 13 421 €20192020 Company: 14 158 €2021 Company: 19 155 €20212022 Company: 79 752 €2023 Company: 23 697 €20232024 Company: 19 170 €2025 Company: 4 991 €2025
Equity, € 2025: 4 961 € · −0.5% vs 2024
010 00020 00030 00040 00050 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 12 573 €20192020 Company: 13 472 €20202021 Company: 17 389 €20212022 Company: 47 732 €20222023 Company: 3 779 €20232024 Company: 4 984 €20242025 Company: 4 961 €2025010 00020 00030 00040 00050 0002018 Company: —2019 Company: 12 573 €20192020 Company: 13 472 €2021 Company: 17 389 €20212022 Company: 47 732 €2023 Company: 3 779 €20232024 Company: 4 984 €2025 Company: 4 961 €2025
Employees 2025: 1 · +0.0% vs 2024 · industry median 1 · above 5% of the industry
0.00.51.01.52.02016 Company: 0 Industry median: —20162017 Company: 0 Industry median: —20172018 Company: 0 Industry median: 120182019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 1 Industry median: 120232024 Company: 1 Industry median: 120242025 Company: 1 Industry median: 120250.00.51.01.52.02018 Company: 0 Industry median: 12019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 1 Industry median: 120232024 Company: 1 Industry median: 12025 Company: 1 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 -23 0 4 991 4 961 1
2024 93 435 1 205 0 19 170 4 984 1
2023 16 621 -43 953 883 23 697 3 779 1
2022 147 232 44 343 0 79 752 47 732 0
2021 11 031 3 917 0 19 155 17 389 0
2020 12 051 899 0 14 158 13 472 0
2019 5 624 -4 501 0 13 421 12 573 0
2018 — — — — — 0
2017 — — — — — 0
2016 — — — — — 0
2015 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
-0.5 %
Net profit / equity
Return on assets (ROA)
-0.5 %
Net profit / assets
Equity ratio
99.4 %
Equity / assets
Debt ratio
0.6 %
Liabilities / assets
Current ratio
166.37
Current assets / current liabilities
Revenue per employee
0 €
Revenue / average full-time employees
Labour cost per employee per month
0 €
Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 10 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 10 Mar 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 3 Mar 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 19 Mar 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 31 Jan 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 27 May 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 5 Nov 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 72101Research and experimental development on natural sciences and engineering Main
Rulings
Number, date Title Deadline State Document
Ä 50000020 / 10
25 May 2026
Entry refused In force
26 Jun 2026
PDF
Ä 50000020 / 9
18 Jun 2025
Amendment entry In force
18 Jun 2025
PDF
Ä 50000020 / 8
1 Sep 2023
Amendment entry In force
1 Sep 2023
PDF
Ä 50000020 / 7
31 Jan 2022
Amendment entry In force
31 Jan 2022
PDF
Ä 50000020 / 6
14 Jun 2021
Entry refused: deficiencies not eliminated In force
1 Jul 2021
PDF
Ä 50000020 / M3
28 May 2021
Ruling to eliminate deficiencies 11 Jun 2021 In force
28 May 2021
PDF
Ä 50000020 / 5
4 Feb 2019
Amendment entry In force
4 Feb 2019
PDF
Ä 50000020 / M2
9 Jan 2019
Ruling to eliminate deficiencies 24 Jan 2019 Deficiencies eliminated
4 Feb 2019
PDF
Ä 50000020 / M1
13 Dec 2018
Ruling to eliminate deficiencies 2 Jan 2019 Deficiencies eliminated
4 Feb 2019
PDF
Ä 50000020 / 4
19 Jan 2018
Amendment entry In force
19 Jan 2018
PDF
Ä 50000020 / 3
9 Dec 2017
Amendment entry In force
9 Dec 2017
PDF
Ä 50000020 / 2
26 Feb 2016
Amendment under Commercial Code § 525 (2) In force
26 Feb 2016
PDF
Ä 50000020
2 Jan 2015
First entry In force
2 Jan 2015
PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data